• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Philips satisfied with medical results

Article

Dutch conglomerate Philips Electronics last month reported that1996 sales in its Philips Medical Systems unit progressed welland that the company was satisfied with the division's operatingincome. Philips declined to break out specific sales and

Dutch conglomerate Philips Electronics last month reported that1996 sales in its Philips Medical Systems unit progressed welland that the company was satisfied with the division's operatingincome. Philips declined to break out specific sales and profitfigures for the unit, which is part of Philips' Professional Productsand Systems business.

As a whole, however, Philips reported disappointing financialresults for 1996, due to losses in its Grundig division and restructuringcharges. For the year, Philips Electronics posted revenues of$36.82 billion (69.2 billion Dutch guilders), up 7% compared with$34.3 billion in sales in 1995. The company had a net loss for1996 of $313.4 million, compared with net income in 1995 of $1.34billion.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.